Brexit – What are the potential consequences for pharma patents and SPCs
Brexit raises a number of difficult questions with regard to intellectual property rights in a post-Brexit world, particularly for UK based pharma companies. Whilst the position with regard to the current European patent system is unchanged, the fate of the unitary patent and the unified patent cour...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Huddersfield Press
2017-09-01
|
| Series: | British Journal of Pharmacy |
| Online Access: | https://www.bjpharm.org.uk/article/id/32/ |